Logo image of MIR.CA

MEDMIRA INC (MIR.CA) Stock Fundamental Analysis

TSX-V:MIR - TSX Venture Exchange - CA58501R1029 - Common Stock - Currency: CAD

0.085  0 (0%)

Fundamental Rating

0

MIR gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of MIR have multiple concerns. MIR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MIR has reported negative net income.
In the past year MIR has reported a negative cash flow from operations.
In the past 5 years MIR always reported negative net income.
In the past 5 years MIR always reported negative operating cash flow.
MIR.CA Yearly Net Income VS EBIT VS OCF VS FCFMIR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

MIR has a Return On Assets (-106.12%) which is in line with its industry peers.
Industry RankSector Rank
ROA -106.12%
ROE N/A
ROIC N/A
ROA(3y)-58.63%
ROA(5y)-50.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR.CA Yearly ROA, ROE, ROICMIR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

MIR has a better Gross Margin (67.23%) than 78.57% of its industry peers.
In the last couple of years the Gross Margin of MIR has declined.
MIR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.9%
GM growth 5Y-7.32%
MIR.CA Yearly Profit, Operating, Gross MarginsMIR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

MIR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MIR has been increased compared to 5 years ago.
The debt/assets ratio for MIR has been reduced compared to a year ago.
MIR.CA Yearly Shares OutstandingMIR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MIR.CA Yearly Total Debt VS Total AssetsMIR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

MIR has an Altman-Z score of -36.63. This is a bad value and indicates that MIR is not financially healthy and even has some risk of bankruptcy.
MIR has a Altman-Z score of -36.63. This is in the lower half of the industry: MIR underperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -36.63
ROIC/WACCN/A
WACCN/A
MIR.CA Yearly LT Debt VS Equity VS FCFMIR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

2.3 Liquidity

A Current Ratio of 0.09 indicates that MIR may have some problems paying its short term obligations.
MIR's Current ratio of 0.09 is on the low side compared to the rest of the industry. MIR is outperformed by 92.86% of its industry peers.
MIR has a Quick Ratio of 0.09. This is a bad value and indicates that MIR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MIR (0.08) is worse than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.08
MIR.CA Yearly Current Assets VS Current LiabilitesMIR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for MIR have decreased strongly by -52.38% in the last year.
The Revenue for MIR has decreased by -32.12% in the past year. This is quite bad
MIR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.79% yearly.
EPS 1Y (TTM)-52.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.5%
Revenue 1Y (TTM)-32.12%
Revenue growth 3Y-42.27%
Revenue growth 5Y-4.79%
Sales Q2Q%-53.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MIR.CA Yearly Revenue VS EstimatesMIR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MIR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MIR.CA Price Earnings VS Forward Price EarningsMIR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MIR.CA Per share dataMIR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0.01 -0.01 -0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MIR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDMIRA INC

TSX-V:MIR (5/30/2025, 7:00:00 PM)

0.085

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-27 2025-03-27
Earnings (Next)06-27 2025-06-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap64.46M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 232.86
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -106.12%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.23%
FCFM N/A
ROA(3y)-58.63%
ROA(5y)-50.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.9%
GM growth 5Y-7.32%
F-Score2
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.08
Altman-Z -36.63
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.12%
Revenue growth 3Y-42.27%
Revenue growth 5Y-4.79%
Sales Q2Q%-53.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-322.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-361.56%
OCF growth 3YN/A
OCF growth 5YN/A